Johnson & Johnson Announces Commitment To Adopt Revised PhRMA Marketing Code for Responsible Interactions With Healthcare ProfessionalsPharmaceutical companies in the Johnson & Johnson Family of Companies to abide by the revised Code
NEW BRUNSWICK, N.J., July 10, 2008 /PRNewswire-FirstCall/ -- Johnson & Johnson today announced the commitment by its pharmaceutical companies to adopt the revised Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals. PhRMA introduced its new Code earlier today.
Maintaining ethical relationships with health care professionals is an essential aspect of providing physicians with the valuable information regarding the appropriate use of medicines needed to help provide the best possible care for patients. Acceptance of the revised PhRMA Code is consistent with Johnson & Johnson's ongoing commitment to ensure the integrity of our relationships between representatives and doctors, as well as to protect medical judgment and treatment choices from inappropriate influence.
The revised Code will supplement and enhance measures adopted by Johnson & Johnson and its pharmaceutical operating companies in 2002 when the first PhRMA Code was introduced. Operating companies within our Pharmaceuticals Group will implement the new guidance by January 2009.
Johnson & Johnson and its involved operating companies base their guidelines for responsible interactions with doctors on industry codes of conduct as well as the legal, regulatory and professional requirements of the countries where we conduct business.
CONTACT: Stephanie Scott of Johnson & Johnson, +1-732-524-1762
Web site: http://www.jnj.com/
Company News On-Call: http://www.prnewswire.com/comp/467347.html /
Ticker Symbol: (:JNJ)
Terms and conditions of use apply
Copyright © 2008 PR Newswire Association LLC. All rights reserved.
A United Business Media Company
Posted: July 2008